188. Brand, W.; Peters, R.J.B.; Braakhuis, H.M.; Maślankiewicz, L.; Oomen, A.G. Possible effects of titanium dioxide particles on human liver, intestinal tissue, spleen and kidney after oral exposure. *Nanotoxicology* **2020**, *14*, 985–1007. https://doi.org/10.1080/17435390.2020.1778809.

189. Elsabahy, M.; Wooley, K.L. Cytokines as biomarkers of nanoparticle immunotoxicity. *Chem. Soc. Rev.* **2013**, *42*, 5552–5576. https://doi.org/10.1039/c3cs60064e.

190. Di Ianni, E.; Erdem, J.S.; Møller, P.; Sahlgren, N.M.; Poulsen, S.S.; Knudsen, K.B.; Zienolddiny, S.; Saber, A.T.; Wallin, H.; Vogel, U.; et al. In vitro-in vivo correlations of pulmonary inflammogenicity and genotoxicity of MWCNT. *Part. Fibre Toxicol.* **2021**, *18*, 25. https://doi.org/10.1186/s12989-021-00413-2.

191. Sun, B.; Wang, X.; Ji, Z.; Li, R.; Xia, T. NLRP3 Inflammasome Activation Induced by Engineered Nanomaterials. *Small* **2013**, *9*, 1595–1607. https://doi.org/10.1002/smll.201201962.

192. Harkema, J.R.; Wagner, J.G. Pathology of the Respiratory System. In *Toxicologic Pathology for Non-Pathologists*; Humana: New York, NY, USA, 2019; pp. 311–354. https://doi.org/10.1007/978-1-4939-9777-0_9.

193. Li, Y.; Fujita, M.; Boraschi, D. Endotoxin Contamination in Nanomaterials Leads to the Misinterpretation of Immunosafety Results. *Front. Immunol.* **2017**, *8*, 472. https://doi.org/10.3389/fimmu.2017.00472.

194. Dobrovolskaia, M.A.; Germolec, D.R.; Weaver, J.L. Evaluation of nanoparticle immunotoxicity. *Nat. Nanotechnol.* **2009**, *4*, 411–414. https://doi.org/10.1038/nnano.2009.175.

195. Braakhuis, H.M.; Gremmer, E.R.; Bannuscher, A.; Drasler, B.; Keshavan, S.; Barbara Rothen-Rutishauser, B.B.; Verlohner, A.; Landsiedel, R.; Meldrum, K.; Doak, S.H.; et al. Transferability and reproducibility of exposed air-liquid interface co-culture lung models. *NanoImpact*. 2022, in preparation.

196. Barosova, H.; Meldrum, K.; Karakocak, B.B.; Balog, S.; Doak, S.H.; Petri-Fink, A.; Clift, M.J.D.; Rothen-Rutishauser, B. Inter-laboratory variability of A549 epithelial cells grown under submerged and air-liquid interface conditions. *Toxicol. In Vitro* **2021**, *75*, 105178. https://doi.org/10.1016/j.tiv.2021.105178.

197. Bessa, M.J.; Brandão, F.; Fokkens, P.; Cassee, F.R.; Salmatonidis, A.; Viana, M.; Vulpoi, A.; Simon, S.; Monfort, E.; Teixeira, J.P.; et al. Toxicity assessment of industrial engineered and airborne process-generated nanoparticles in a 3D human airway epithelial in vitro model. *Nanotoxicology* **2021**, *15*, 542–557. https://doi.org/10.1080/17435390.2021.1897698.

198. Petersen, E.J.; Sharma, M.; Clippinger, A.J.; Gordon, J.; Katz, A.; Laux, P.; Leibrock, L.B.; Luch, A.; Matheson, J.; Stucki, A.O.; et al. Use of Cause-and-Effect Analysis to Optimize the Reliability of In Vitro Inhalation Toxicity Measurements Using an Air-Liquid Interface. *Chem. Res. Toxicol.* **2021**, *34*, 1370–1385. https://doi.org/10.1021/acs.chemrestox.1c00080.

199. Guo, C.; Buckley, A.; Marczylo, T.; Seiffert, J.; Römer, I.; Warren, J.; Hodgson, A.; Chung, K.F.; Gant, T.; Smith, R.; et al. The small airway epithelium as a target for the adverse pulmonary effects of silver nanoparticle inhalation. *Nanotoxicology* **2018**, *12*, 539–553. https://doi.org/10.1080/17435390.2018.1465140.

200. Sandberg, W.J.; Låg, M.; Holme, J.A.; Friede, B.; Gualtieri, M.; Kruszewski, M.; Schwarze, P.E.; Skuland, T.; Refsnes, M. Comparison of non-crystalline silica nanoparticles in IL-1β release from macrophages. *Part. Fibre Toxicol.* **2012**, *9*, 32. https://doi.org/10.1186/1743-8977-9-32.

201. Svensson, C.R.; Ameer, S.S.; Ludvigsson, L.; Ali, N.; Alhamdow, A.; Messing, M.E.; Pagels, J.; Gudmundsson, A.; Bohgard, M.; Sanfins, E.; et al. Validation of an air-liquid interface toxicological set-up using Cu, Pd, and Ag well-characterized nanostructured aggregates and spheres. *J. Nanopart. Res.* **2016**, *18*, 86. https://doi.org/10.1007/s11051-016-3389-y.

202. Endes, C.; Schmid, O.; Kinnear, C.; Mueller, S.; Camarero-Espinosa, S.; Vanhecke, D.; Foster, E.J.; Petri-Fink, A.; Rothen-Rutishauser, B.; Weder, C.; et al. An in vitro testing strategy towards mimicking the inhalation of high aspect ratio nanoparticles. *Part. Fibre Toxicol.* **2014**, *11*, 40. https://doi.org/10.1186/s12989-014-0040-x.

203. Hufnagel, M.; Neuberger, R.; Wall, J.; Link, M.; Friesen, A.; Hartwig, A. Impact of Differentiated Macrophage-Like Cells on the Transcriptional Toxicity Profile of CuO Nanoparticles in Co-Cultured Lung Epithelial Cells. *Int. J. Mol. Sci.* **2021**, *22*, 5044. https://doi.org/10.3390/ijms22095044.

204. Clift, M.J.D.; Endes, C.; Vanhecke, D.; Wick, P.; Gehr, P.; Schins, R.P.F.; Petri-Fink, A.; Rothen-Rutishauser, B. A Comparative Study of Different In Vitro Lung Cell Culture Systems to Assess the Most Beneficial Tool for Screening the Potential Adverse Effects of Carbon Nanotubes. *Toxicol. Sci.* **2014**, *137*, 55–64. https://doi.org/10.1093/toxsci/kft216.

205. Braakhuis, H.M.; He, R.; Vandebriel, R.J.; Gremmer, E.R.; Zwart, E.; Vermeulen, J.P.; Fokkens, P.; Boere, J.; Gosens, I.; Cassee, F.R. An Air-liquid Interface Bronchial Epithelial Model for Realistic, Repeated Inhalation Exposure to Airborne Particles for Toxicity Testing. *J. Vis. Exp.* **2020**, *159*, e61210. https://doi.org/10.3791/61210.

206. Herzog, F.; Clift, M.J.D.; Piccapietra, F.; Behra, R.; Schmid, O.; Petri-Fink, A.; Rothen-Rutishauser, B. Exposure of silver-nanoparticles and silver-ions to lung cells in vitro at the air-liquid interface. *Part. Fibre Toxicol.* **2013**, *10*, 11. https://doi.org/10.1186/1743-8977-10-11.

207. Braakhuis, H.M.; Giannakou, C.; Peijnenburg, W.J.G.M.; Vermeulen, J.; van Loveren, H.; Park, M.V.D.Z. Simplein vitromodels can predict pulmonary toxicity of silver nanoparticles. *Nanotoxicology* **2016**, *10*, 770–779. https://doi.org/10.3109/17435390.2015.1127443.

208. Li, R.; Wang, X.; Ji, Z.; Sun, B.; Zhang, H.; Chang, C.H.; Lin, S.; Meng, H.; Liao, Y.-P.; Wang, M.; et al. Surface Charge and Cellular Processing of Covalently Functionalized Multiwall Carbon Nanotubes Determine Pulmonary Toxicity. *ACS Nano* **2013**, *7*, 2352–2368. https://doi.org/10.1021/nn305567s.

209. Wang, X.; Xia, T.; Ntim, S.A.; Ji, Z.; Lin, S.; Meng, H.; Chung, C.-H.; George, S.; Zhang, H.; Wang, M.; et al. Dispersal State of Multiwalled Carbon Nanotubes Elicits Profibrogenic Cellular Responses That Correlate with Fibrogenesis Biomarkers and Fibrosis in the Murine Lung. *ACS Nano* **2011**, *5*, 9772–9787. https://doi.org/10.1021/nn2033055.
210. Diabaté, S.; Armand, L.; Murugadoss, S.; Dilger, M.; Fritsch-Decker, S.; Schlager, C.; Béal, D.; Arnal, M.-E.; Biola-Clier, M.; Ambrose, S.; et al. Air-Liquid Interface Exposure of Lung Epithelial Cells to Low Doses of Nanoparticles to Assess Pulmonary Adverse Effects. *Nanomaterials* **2020**, *11*, 65. https://doi.org/10.3390/nano11010065.

211. Loret, T.; Rogerieux, F.; Trouiller, B.; Braun, A.; Egles, C.; Lacroix, G. Predicting the in vivo pulmonary toxicity induced by acute exposure to poorly soluble nanomaterials by using advanced in vitro methods. *Part. Fibre Toxicol.* **2018**, *15*, 25. https://doi.org/10.1186/s12989-018-0260-6.

212. Lenz, A.-G.; Karg, E.; Brendel, E.; Hinze-Heyn, H.; Maier, K.L.; Eickelberg, O.; Stoeger, T.; Schmid, O. Inflammatory and Oxidative Stress Responses of an Alveolar Epithelial Cell Line to Airborne Zinc Oxide Nanoparticles at the Air-Liquid Interface: A Comparison with Conventional, Submerged Cell-Culture Conditions. *BioMed Res. Int.* **2013**, *2013*, 652632. https://doi.org/10.1155/2013/652632.

213. Loret, T.; Peyret, E.; Dubreuil, M.; Aguerre-Chariol, O.; Bressot, C.; le Bihan, O.; Amodeo, T.; Trouiller, B.; Braun, A.; Egles, C.; et al. Air-liquid interface exposure to aerosols of poorly soluble nanomaterials induces different biological activation levels compared to exposure to suspensions. *Part. Fibre Toxicol.* **2016**, *13*, 58. https://doi.org/10.1186/s12989-016-0171-3.

214. Herzog, F.; Loza, K.; Balog, S.; Clift, M.J.D.; Epple, M.; Gehr, P.; Petri-Fink, A.; Rothen-Rutishauser, B. Mimicking exposures to acute and lifetime concentrations of inhaled silver nanoparticles by two different in vitro approaches. *Beilstein J. Nanotechnol.* **2014**, *5*, 1357–1370. https://doi.org/10.3762/bjnano.5.149.

215. Medina-Reyes, E.I.; Delgado-Buenrostro, N.L.; Leseman, D.L.; Déciga-Alcaraz, A.; He, R.; Gremmer, E.R.; Fokkens, P.H.B.; Flores-Flores, J.O.; Cassee, F.R.; Chirino, Y.I. Differences in cytotoxicity of lung epithelial cells exposed to titanium dioxide nanofibers and nanoparticles: Comparison of air-liquid interface and submerged cell cultures. *Toxicol. In Vitro* **2020**, *65*, 104798. https://doi.org/10.1016/j.tiv.2020.104798.

216. Panas, A.; Comouth, A.; Saathoff, H.; Leisner, T.; Al-Rawi, M.; Simon, M.; Seemann, G.; Dössel, O.; Mülhopt, S.; Paur, H.-R.; et al. Silica nanoparticles are less toxic to human lung cells when deposited at the air-liquid interface compared to conventional submerged exposure. *Beilstein J. Nanotechnol.* **2014**, *5*, 1590–1602. https://doi.org/10.3762/bjnano.5.171.

217. Öhlinger, K.; Kolesnik, T.; Meindl, C.; Gallé, B.; Absenger-Novak, M.; Kolb-Lenz, D.; Fröhlich, E. Air-liquid interface culture changes surface properties of A549 cells. *Toxicol. In Vitro* **2019**, *60*, 369–382. https://doi.org/10.1016/j.tiv.2019.06.014.

218. Upadhyay, S.; Palmberg, L. Air-Liquid Interface: Relevant In Vitro Models for Investigating Air Pollutant-Induced Pulmonary Toxicity. *Toxicol. Sci.* **2018**, *164*, 21–30. https://doi.org/10.1093/toxsci/kfy053.

219. Bannuscher, A.; Schmid, O.; Drasler, B.; Rohrbasser, A.; Braakhuis, H.M.; Meldrum, K.; Zwart, E.P.; Gremmer, E.R.; Birk, B.; Rissel, M.; et al. An inter-laboratory effort to harmonize the cell-delivered in vitro dose of aerosolized materials. *NanoImpact* **2022**, *28*, 100439. https://doi.org/10.1016/j.impact.2022.100439.

220. Doak, S.H.; Clift, M.J.; Costa, A.; Delmaar, C.; Gosens, I.; Halappanavar, S.; Kelly, S.; Pejinenburg, W.J.; Rothen-Rutishauser, B.; Schins, R.P. The Road to Achieving the European Commission's Chemicals Strategy for Nanomaterial Sustainability—A PATROLS Perspective on New Approach Methodologies. *Small* **2022**, *18*, 2200231.

221. Catalán, J.; Stockmann-Juvala, H.; Norppa, H. A theoretical approach for a weighted assessment of the mutagenic potential of nanomaterials. *Nanotoxicology* **2017**, *11*, 964–977. https://doi.org/10.1080/17435390.2017.1382601.

222. Kohl, Y.; Rundén-Pran, E.; Mariussen, E.; Hesler, M.; El Yamani, N.; Longhin, E.M.; Dusinska, M. Genotoxicity of Nanomaterials: Advanced In Vitro Models and High Throughput Methods for Human Hazard Assessment—A Review. *Nanomaterials* **2020**, *10*, 1911. https://doi.org/10.3390/nano10101911.

223. Hartwig, A.; Arand, M.; Epe, B.; Guth, S.; Jahnke, G.; Lampen, A.; Martus, H.-J.; Monien, B.; Rietjens, I.M.C.M.; Schmitz-Spanke, S.; et al. Mode of action-based risk assessment of genotoxic carcinogens. *Arch. Toxicol.* **2020**, *94*, 1787–1877. https://doi.org/10.1007/s00204-020-02733-2.

224. Steiblen, G.; van Benthem, J.; Johnson, G. Strategies in genotoxicology: Acceptance of innovative scientific methods in a regulatory context and from an industrial perspective. *Mutat. Res./Genet. Toxicol. Environ. Mutagen.* **2020**, *853*, 503171. https://doi.org/10.1016/j.mrgentox.2020.503171.

225. Catalán, J.; Norppa, H. Safety Aspects of Bio-Based Nanomaterials. *Bioengineering* **2017**, *4*, 94. https://doi.org/10.3390/bioengineering4040094.

226. Stone, V.; Pozzi-Mucelli, S.; Tran, L.; Aschberger, K.; Sabella, S.; Vogel, U.; Poland, C.; Balharry, D.; Fernandes, T.; Gottardo, S.; et al. ITS-NANO—Prioritising nanosafety research to develop a stakeholder driven intelligent testing strategy. *Part. Fibre Toxicol.* **2014**, *11*, 9. https://doi.org/10.1186/1743-8977-11-9.

227. Dusinska, M.; Boland, S.; Saunders, M.; Juillerat-Jeanneret, L.; Tran, L.; Pojana, G.; Marcomini, A.; Volkovova, K.; Tulinska, J.; Knudsen, L.E.; et al. Towards an alternative testing strategy for nanomaterials used in nanomedicine: Lessons from NanoTEST. *Nanotoxicology* **2015**, *9*, 118–132. https://doi.org/10.3109/17435390.2014.991431.

228. Kirkland, D.; Reeve, L.; Gatehouse, D.; Vanparys, P. A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. *Mutat. Res./Genet. Toxicol. Environ. Mutagen.* **2011**, *721*, 27–73. https://doi.org/10.1016/j.mrgentox.2010.12.015.

229. Kirkland, D.; Aardema, M.; Henderson, L.; Müller, L. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. *Mutat. Res./Genet. Toxicol. Environ. Mutagen.* **2005**, *584*, 1–256. https://doi.org/10.1016/j.mrgentox.2005.10.002.

230. Doak, S.H.; Manshian, B.; Jenkins, G.J.S.; Singh, N. In vitro genotoxicity testing strategy for nanomaterials and the adaptation of current OECD guidelines. *Mutat. Res. Toxicol. Environ. Mutagen.* **2012**, *745*, 104–111. https://doi.org/10.1016/j.mrgentox.2011.09.013.
231. Clift, M.J.D.; Raemy, D.O.; Endes, C.; Ali, Z.; Lehmann, A.D.; Brandenberger, C.; Petri-Fink, A.; Wick, P.; Parak, W.J.; Gehr, P.; et al. Can the Ames test provide an insight into nano-object mutagenicity? Investigating the interaction between nano-objects and bacteria. *Nanotoxicology* **2013**, *7*, 1373–1385. https://doi.org/10.3109/17435390.2012.741725.

232. George, J.M.; Magogotya, M.; Vetten, M.A.; Buys, A.V.; Gulumian, M. From the cover: An investigation of the genotoxicity and interference of gold nanoparticles in commonly used in vitro mutagenicity and genotoxicity assays. *Toxicol. Sci.* **2017**, *156*, 149–166.

233. Landsiedel, R.; Kapp, M.D.; Schulz, M.; Wiench, K.; Oesch, F. Genotoxicity investigations on nanomaterials: Methods, preparation and characterization of test material, potential artifacts and limitations—Many questions, some answers. *Mutat. Res./Rev. Mutat. Res.* **2009**, *681*, 241–258. https://doi.org/10.1016/j.mrrev.2008.10.002.

234. Magdolenova, Z.; Collins, A.; Kumar, A.; Dhawan, A.; Stone, V.; Dusinska, M. Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticles. *Nanotoxicology* **2014**, *8*, 233–278. https://doi.org/10.3109/17435390.2013.773464.

235. Pfuhler, S.; Elespuru, R.; Aardema, M.J.; Doak, S.H.; Maria Donner, E.; Honma, M. Genotoxicity of nanomaterials: Refining strategies and tests for hazard identification. *Environ. Mol. Mutagen.* **2013**, *54*, 229.

236. Elespuru, R.; Pfuhler, S.; Aardema, M.J.; Chen, T.; Doak, S.H.; Doherty, A.; Farabaugh, C.S.; Kenny, J.; Manjanatha, M.; Mahadevan, B.; et al. Genotoxicity Assessment of Nanomaterials: Recommendations on Best Practices, Assays, and Methods. *Toxicol. Sci.* **2018**, *164*, 391–416. https://doi.org/10.1093/toxsci/kfy100.

237. Elespuru, R.K.; Doak, S.H.; Collins, A.R.; Dusinska, M.; Pfuhler, S.; Manjanatha, M.; Cardoso, R.; Chen, C.L. Common Considerations for Genotoxicity Assessment of Nanomaterials. *Front. Toxicol.* **2022**, *4*, 859122. https://doi.org/10.3389/ftox.2022.859122.

238. Fenech, M.; Morley, A.A. Cytokinesis-block micronucleus method in human lymphocytes: Effect of in vivo ageing and low dose X-irradiation. *Mutat. Res./Fundam. Mol. Mech. Mutagen.* **1986**, *161*, 193–198. https://doi.org/10.1016/0027-5107(86)90010-2.

239. Doak, S.; Griffiths, S.; Manshian, B.; Singh, N.; Williams, P.; Brown, A.; Jenkins, G. Confounding experimental considerations in nanogenotoxicology. *Mutagenesis* **2009**, *24*, 285–293. https://doi.org/10.1093/mutage/gep010.

240. ECHA. Guidance on Information Requirements and Chemical Safety Assessment; Appendix R7-1 for Nanomaterials Applicable to Chapter R7a Endpoint Specific Guidance ECHA-21-H-04-EN; ECHA: Helsinki, Finland, 2021.

241. Dusinska, M.; Mariussen, E.; Rundén-Pran, E.; Hudecova, A.M.; Elje, E.; Kazimirova, A.; El Yamani, N.; Dommershausen, N.; Tharmann, J.; Fieblinger, D.; et al. In Vitro Approaches for Assessing the Genotoxicity of Nanomaterials. In *Nanotoxicity; Methods in Molecular Biology*; Springer: Cham, Switzerland, 2019; Volume 1894, pp. 83–122. https://doi.org/10.1007/978-1-4939-8916-4_6.

242. Wills, J.W.; Hondow, N.; Thomas, A.D.; Chapman, K.E.; Fish, D.; Maffeis, T.G.; Penny, M.W.; Brown, R.A.; Jenkins, G.J.S.; Brown, A.P.; et al. Genetic toxicity assessment of engineered nanoparticles using a 3D in vitro skin model (EpiDerm™). *Part. Fibre Toxicol.* **2016**, *13*, 50. https://doi.org/10.1186/s12989-016-0161-5.

243. Conway, G.E.; Shah, U.-K.; Llewellyn, S.; Cervena, T.; Evans, S.J.; Al Ali, A.S.; Jenkins, G.J.; Clift, M.J.D.; Doak, S.H. Adaptation of the in vitro micronucleus assay for genotoxicity testing using 3D liver models supporting longer-term exposure durations. *Mutagenesis* **2020**, *35*, 319–330. https://doi.org/10.1093/mutage/geaa018.

244. ANSES. Nanogenotox Final Report—Facilitating the Safety Evaluation of Manufactured Nanomaterials by Characterising Their Potential Genotoxic Hazard; ANSES: Buenos Aires, Argentina, 2013.

245. Louro, H.; Pinhão, M.; Santos, J.; Tavares, A.; Vital, N.; Silva, M.J. Evaluation of the cytotoxic and genotoxic effects of benchmark multi-walled carbon nanotubes in relation to their physicochemical properties. *Toxicol. Lett.* **2016**, *262*, 123–134. https://doi.org/10.1016/j.toxlet.2016.09.016.

246. Evans, S.J.; Clift, M.J.D.; Singh, N.; Wills, J.W.; Hondow, N.; Wilkinson, T.S.; Burgum, M.J.; Brown, A.P.; Jenkins, G.J.; Doak, S.H. In vitro detection of in vitro secondary mechanisms of genotoxicity induced by engineered nanomaterials. *Part. Fibre Toxicol.* **2019**, *16*, 8. https://doi.org/10.1186/s12989-019-0291-7.

247. Burgum, M.J.; Clift, M.J.D.; Evans, S.J.; Hondow, N.; Tarat, A.; Jenkins, G.J.; Doak, S.H. Few-layer graphene induces both primary and secondary genotoxicity in epithelial barrier models in vitro. *J. Nanobiotechnol.* **2021**, *19*, 24. https://doi.org/10.1186/s12951-021-00769-9.

248. SCOEL. Methodology for Derivation of Occupational Exposure Limits of Chemical Agents; European Commission, Ed.; SCOEL: Brussels, Belgium, 2017.

249. Decordier, I.; Papine, A.; Loock, K.V.; Plas, G.; Soussaline, F.; Kirsch-Volders, M. Automated image analysis of micronuclei by IMSTAR for biomonitoring. *Mutagenesis* **2011**, *26*, 163–168. https://doi.org/10.1093/mutage/geq063.

250. Nüsse, M.; Kramer, J. Flow cytometric analysis of micronuclei found in cells after irradiation. *Cytometry* **1984**, *5*, 20–25. https://doi.org/10.1002/cyto.990050105.

251. Nüsse, M.; Marx, K. Flow cytometric analysis of micronuclei in cell cultures and human lymphocytes: Advantages and disadvantages. *Mutat. Res./Genet. Toxicol. Environ. Mutagen.* **1997**, *392*, 109–115. https://doi.org/10.1016/s0165-1218(97)00049-9.

252. Nüsse, M.; Recknagel, S.; Beisker, W. Micronuclei induced by 2-chlorobenzylidene malonitrile contain single chromosomes as demonstrated by the combined use of flow cytometry and immunofluorescent staining with anti-kinetochore antibodies. *Mutagenesis* **1992**, *7*, 57–67. https://doi.org/10.1093/mutage/7.1.57.

253. Franz, P.; Bürkle, A.; Wick, P.; Hirsch, C. Exploring Flow Cytometry-Based Micronucleus Scoring for Reliable Nanomaterial Genotoxicity Assessment. *Chem. Res. Toxicol.* **2020**, *33*, 2538–2549. https://doi.org/10.1021/acs.chemrestox.0c00071.

254. Azqueta, A.; Gutzkow, K.B.; Priestley, C.C.; Meier, S.; Walker, J.S.; Brunborg, G.; Collins, A.R. A comparative performance test of standard, medium- and high-throughput comet assays. *Toxicol. In Vitro* **2013**, *27*, 768–773. https://doi.org/10.1016/j.tiv.2012.12.006.

255. García-Rodríguez, A.; Rubio, L.; Vila, L.; Xamena, N.; Velázquez, A.; Marcos, R.; Hernández, A. The Comet Assay as a Tool to Detect the Genotoxic Potential of Nanomaterials. *Nanomaterials* **2019**, *9*, 1385. https://doi.org/10.3390/nano9101385.
256. Nelson, B.C.; Wright, C.W.; Ibuki, Y.; Moreno-Villanueva, M.; Karlsson, H.L.; Hendriks, G.; Sims, C.M.; Singh, N.; Doak, S.H. Emerging Metrology for High-Throughput Nanomaterial Genotoxicology Mutagenesis Advance Access. *Mutagenesis* **2017**, *32*, 215.

257. Elje, E.; Mariussen, E.; Moriones, O.H.; Bastús, N.G.; Puntes, V.; Kohl, Y.; Dusinska, M.; Rundén-Pran, E. Hepato(Geno)Toxicity Assessment of Nanoparticles in a HepG2 Liver Spheroid Model. *Nanomaterials* **2020**, *10*, 545. https://doi.org/10.3390/nano10030545.

258. Rodriguez-Garraus, A.; Azqueta, A.; Vettorazzi, A.; de Cerain, A.L. Genotoxicity of Silver Nanoparticles. *Nanomaterials* **2020**, *10*, 251. https://doi.org/10.3390/nano10020251.

259. Warheit, D.B.; Donner, E.M. Rationale of genotoxicity testing of nanomaterials: Regulatory requirements and appropriateness of available OECD test guidelines. *Nanotoxicology* **2010**, *4*, 409–413. https://doi.org/10.3109/17435390.2010.485704.

260. Pfuhler, S.; van Benthem, J.; Curren, R.; Doak, S.H.; Dusinska, M.; Hayashi, M.; Heflich, R.H.; Kidd, D.; Kirkland, D.; Luan, Y.; et al. Use of in vitro 3D tissue models in genotoxicity testing: Strategic fit, validation status and way forward. Report of the working group from the 7th International Workshop on Genotoxicity Testing (IWGT). *Mutat. Res./Genet. Toxicol. Environ. Mutagen.* **2020**, *850–851*, 503135. https://doi.org/10.1016/j.mrgentox.2020.503135.

261. Evans, S.J.; Clift, M.J.; Singh, N.; de Oliveira Mallia, J.; Burgum, M.; Wills, J.W.; Wilkinson, T.S.; Jenkins, G.J.; Doak, S.H. Critical review of the current and future challenges associated with advanced in vitro systems towards the study of nanoparticle (secondary) genotoxicity. *Mutagenesis* **2017**, *32*, 233–241. https://doi.org/10.1093/mutage/gew054.

262. Di Ianni, E.; Jacobsen, N.R.; Vogel, U.; Møller, P. Predicting nanomaterials pulmonary toxicity in animals by cell culture models: Achievements and perspectives. *Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol.* **2022**, *14*, e1794. https://doi.org/10.1002/wnan.1794.

263. Clewell, R.A.; McMullen, P.D.; Adeleye, Y.; Carmichael, P.L.; Andersen, M.E. Pathway based toxicology and fit-for-purpose assays. In *Validation of Alternative Methods for Toxicity Testing*; Springer: Cham, Switzerland, 2016; pp. 205–230.

264. Nymark, P.; Bakker, M.; Dekkers, S.; Franken, R.; Fransman, W.; García-Bilbao, A.; Greco, D.; Gulumian, M.; Hadrup, N.; Halappanavar, S.; et al. Toward Rigorous Materials Production: New Approach Methodologies Have Extensive Potential to Improve Current Safety Assessment Practices. *Small* **2020**, *16*, e1904749. https://doi.org/10.1002/smll.201904749.

265. OECD. Guidance Document on the Validation and International Acceptance of New or Updated Test Methods for Hazard Assessment; OECD Environment, Health and Safety Publications Series on Testing and Assessment; OECD: Paris, France, 2015.

266. Clift, M.J.D.; Jenkins, G.J.S.; Doak, S.H. An Alternative Perspective towards Reducing the Risk of Engineered Nanomaterials to Human Health. *Small* **2020**, *16*, e2002002. https://doi.org/10.1002/smll.202002002.

267. Van der Zalm, A.J.; Barroso, J.; Browne, P.; Casey, W.; Gordon, J.; Henry, T.R.; Kleinstreuer, N.C.; Lowit, A.B.; Perron, M.; Clippinger, A.J. A framework for establishing scientific confidence in new approach methodologies. *Arch. Toxicol.* **2022**, *96*, 2865–2879. https://doi.org/10.1007/s00204-022-03365-4.

268. European Commission. *Pathway to a Healthy Planet for All. EU Action Plan: 'Towards Zero Pollution for Air, Water and Soil' — Communication from the Commission to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions*; European Commission: Brussels, Belgium, 2021.

269. Napierska, D.; Thomassen, L.C.J.; Lison, D.; Martens, J.A.; Hoet, P.H. The nanosilica hazard: Another variable entity. *Part. Fibre Toxicol.* **2010**, *7*, 39. https://doi.org/10.1186/1743-8977-7-39.

270. IARC. Arsenic, metals, fibres, and dusts. *IARC Monogr. Eval. Carcinog. Risks Hum.* **2012**, *100*, 11–465.

271. Höck, J.; Behra, R.; Bergamin, L.; Bourqui-Pittet, M.; Bosshard, C.; Epprecht, T.; Furrer, V.; Frey, S.; Gautschi, M.; Hofmann, H.; et al. Guidelines on the Precautionary Matrix for Synthetic Nanomaterials; Federal Office of Public Health: Bern, Switzerland, 2018.

272. Pavlicek, A.; Part, F.; Gressler, S.; Rose, G.; Gazsó, A.; Ehmoser, E.-K.; Huber-Humer, M. Testing the Applicability of the Safe-by-Design Concept: A Theoretical Case Study Using Polymer Nanoclay Composites for Coffee Capsules. *Sustainability* **2021**, *13*, 13951. https://doi.org/10.3390/su132413951.

273. OECD. Testing Programme of Manufactured Nanomaterials. Available online: https://www.oecd.org/chemicalsafety/nanosafety/testing-programme-manufactured-nanomaterials.htm (accessed on 14 November 2022).

274. NanoSafetyCluster. The Malta Initiative. Available online: https://www.nanosafetycluster.eu/international-cooperation/the-malta-initiative/ (accessed on 14 November 2022).

275. NanoHarmony. Available online: https://nanoharmony.eu/ (accessed on 14 November 2022).

276. OECD. Nanomet. Available online: https://www.oecd.org/chemicalsafety/nanomet/ (accessed on 14 November 2022).

277. Gov4Nano. Available online: https://www.gov4nano.eu/ (accessed on 14 November 2022).

278. EFSA; Andersson, N.; Arena, M.; Auteri, D.; Barmaz, S.; Grignard, E.; Kienzler, A.; Lepper, P.; Lostia, A.M.; Munn, S. Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528/2012 and (EC) No 1107/2009. *EFSA J. Food Safety* **2018**, *16*, e05311.

279. Shen, F.; Li, D.; Guo, J.; Chen, J. Mechanistic toxicity assessment of differently sized and charged polystyrene nanoparticles based on human placental cells. *Water Res.* **2022**, *223*, 118960. https://doi.org/10.1016/j.watres.2022.118960.

280. Priyam, A.; Singh, P.P.; Gehlout, S. Role of Endocrine-Disrupting Engineered Nanomaterials in the Pathogenesis of Type 2 Diabetes Mellitus. *Front. Endocrinol.* **2018**, *9*, 704. https://doi.org/10.3389/fendo.2018.00704.

**Disclaimer/Publisher's Note:** The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.